These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection. Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027 [TBL] [Abstract][Full Text] [Related]
25. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups. Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858 [TBL] [Abstract][Full Text] [Related]
26. Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique. Richardson SC; Grimwood K; Bishop RF J Clin Microbiol; 1993 Feb; 31(2):377-85. PubMed ID: 8381813 [TBL] [Abstract][Full Text] [Related]
27. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children. Gorrell RJ; Bishop RF J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409 [TBL] [Abstract][Full Text] [Related]
28. Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus. Fiore L; Dunn SJ; Ridolfi B; Ruggeri FM; Mackow ER; Greenberg HB J Gen Virol; 1995 Aug; 76 ( Pt 8)():1981-8. PubMed ID: 7636478 [TBL] [Abstract][Full Text] [Related]
29. Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. Ijaz MK; Attah-Poku SK; Redmond MJ; Parker MD; Sabara MI; Frenchick P; Babiuk LA J Virol; 1991 Jun; 65(6):3106-13. PubMed ID: 1851871 [TBL] [Abstract][Full Text] [Related]
31. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine. Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444 [TBL] [Abstract][Full Text] [Related]
32. Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. Wu YZ; Li JT; Mou ZR; Fei L; Ni B; Geng M; Jia ZC; Zhou W; Zou LY; Tang Y Virology; 2003 Sep; 313(2):337-42. PubMed ID: 12954202 [TBL] [Abstract][Full Text] [Related]
33. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. Offit PA; Clark HF; Blavat G; Greenberg HB J Virol; 1986 Nov; 60(2):491-6. PubMed ID: 3021983 [TBL] [Abstract][Full Text] [Related]
34. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401 [TBL] [Abstract][Full Text] [Related]
35. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. Choi AH; Basu M; McNeal MM; Clements JD; Ward RL J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847 [TBL] [Abstract][Full Text] [Related]
36. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus. Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537 [TBL] [Abstract][Full Text] [Related]
37. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. Schwartz-Cornil I; Benureau Y; Greenberg H; Hendrickson BA; Cohen J J Virol; 2002 Aug; 76(16):8110-7. PubMed ID: 12134016 [TBL] [Abstract][Full Text] [Related]
38. Homotypic immune response to primary infection with rotavirus serotype G1. Rojas AM; Boher Y; Guntiñas MJ; Pérez-Schael I J Med Virol; 1995 Dec; 47(4):404-9. PubMed ID: 8636710 [TBL] [Abstract][Full Text] [Related]
39. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Burns JW; Siadat-Pajouh M; Krishnaney AA; Greenberg HB Science; 1996 Apr; 272(5258):104-7. PubMed ID: 8600516 [TBL] [Abstract][Full Text] [Related]
40. Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children. Menchaca G; Padilla-Noriega L; Méndez-Toss M; Contreras JF; Puerto FI; Guiscafré H; Mota F; Herrera I; Cedillo R; Muñoz O; Ward R; Hoshino Y; López S; Arias CF Clin Diagn Lab Immunol; 1998 May; 5(3):328-34. PubMed ID: 9605987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]